Tag Archives: Tafenoquine

Alliance of Defence Service Organisations – Advocacy for Australian Mefloquine and Tafenoquine Veterans

The Alliance of Defence Service Organisations (ADSO) comprises 14 organisations that represent the interests of serving Australian Defence Force personnel and veterans, totalling around 100,000 members. Their key role is to provide national advocacy and representation to the Australian Federal Parliament … Continue reading

Posted in Advocacy, Support | Tagged , , , , | Leave a comment

Feature Story (2004) – 1300 Troops Took ‘Guinea Pig’ Drug

Luke McIlveen and Ian McPhedran, 1300 troops took ‘guinea pig’ drug, The Sunday Telegraph, 31 October 2004.   THE Army has admitted more than 1300 troops who served in East Timor were given an anti-malaria drug with potentially devastating side effects. Army … Continue reading

Posted in Clinical Drug Trials, Media | Tagged , , , , , , , | 1 Comment

Featured Research – Sean R Marcsisin et al, Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds

Background Tafenoquine (TQ) is an 8-aminoquinoline (8AQ) that has been tested in several Phase II and Phase III clinical studies and is currently in late stage development as an anti-malarial prophylactic agent. NPC-1161B is a promising 8AQ in late preclinical … Continue reading

Posted in Research | Tagged , , | Leave a comment